[Development of a screening tool for migraine prophylaxis]

A Wissmann; A Feuersenger; A Gendolla; U Reuter; A Straube; S Evers; Arne May; A Peikert; V Pfaffenrath; H Staudenmayer; H-C Diener

[Development of a screening tool for migraine prophylaxis]

Standard

[Development of a screening tool for migraine prophylaxis]. / Wissmann, A; Feuersenger, A; Gendolla, A; Reuter, U; Straube, A; Evers, S; May, Arne; Peikert, A; Pfaffenrath, V; Staudenmayer, H; Diener, H-C.

In: SCHMERZ, Vol. 21, No. 5, 5, 2007, p. 430-438.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Wissmann, A, Feuersenger, A, Gendolla, A, Reuter, U, Straube, A, Evers, S, May, A, Peikert, A, Pfaffenrath, V, Staudenmayer, H & Diener, H-C 2007, '[Development of a screening tool for migraine prophylaxis]', SCHMERZ, vol. 21, no. 5, 5, pp. 430-438. <http://www.ncbi.nlm.nih.gov/pubmed/17323045?dopt=Citation>

APA

Wissmann, A., Feuersenger, A., Gendolla, A., Reuter, U., Straube, A., Evers, S., May, A., Peikert, A., Pfaffenrath, V., Staudenmayer, H., & Diener, H-C. (2007). [Development of a screening tool for migraine prophylaxis]. SCHMERZ, 21(5), 430-438. [5]. http://www.ncbi.nlm.nih.gov/pubmed/17323045?dopt=Citation

Vancouver

Wissmann A, Feuersenger A, Gendolla A, Reuter U, Straube A, Evers S et al. [Development of a screening tool for migraine prophylaxis]. SCHMERZ. 2007;21(5):430-438. 5.

Bibtex

@article{836649e5de5346dfab0006caf10d4f14,

title = "[Development of a screening tool for migraine prophylaxis]",

abstract = "The aim of the present study was to develop a screening tool to aid non-headache specialists, like general practitioners, in deciding whether migraine prophylaxis in the individual migraine patient is useful or not. The first step was the development of a questionnaire, consisting of 10 items, which was filled in by 132 migraineurs who called on neurologists or headache experts. Independently, the physicians filled in another questionnaire to answer the question of whether they decided to prescribe migraine prophylaxis and if they had, to give their reasons for doing so. Using logistic regression analysis, we identified the three questions which had the most influence on the decision regarding prophylaxis in the data set. As results, we identified the following three questions: 1. Do you suffer from migraine on more than 3 days/month? 2. Do you have to rest in bed while experiencing a migraine attack? 3. Do you have to take medication against migraine on more than 5 days/month? Validation of this reduced questionnaire is currently ongoing and involves 150 migraine patients of general practitioners.",

author = "A Wissmann and A Feuersenger and A Gendolla and U Reuter and A Straube and S Evers and Arne May and A Peikert and V Pfaffenrath and H Staudenmayer and H-C Diener",

year = "2007",

language = "Deutsch",

volume = "21",

pages = "430--438",

journal = "SCHMERZ",

issn = "0932-433X",

publisher = "Springer",

number = "5",

}

RIS

TY - JOUR

T1 - [Development of a screening tool for migraine prophylaxis]

AU - Wissmann, A

AU - Feuersenger, A

AU - Gendolla, A

AU - Reuter, U

AU - Straube, A

AU - Evers, S

AU - May, Arne

AU - Peikert, A

AU - Pfaffenrath, V

AU - Staudenmayer, H

AU - Diener, H-C

PY - 2007

Y1 - 2007

N2 - The aim of the present study was to develop a screening tool to aid non-headache specialists, like general practitioners, in deciding whether migraine prophylaxis in the individual migraine patient is useful or not. The first step was the development of a questionnaire, consisting of 10 items, which was filled in by 132 migraineurs who called on neurologists or headache experts. Independently, the physicians filled in another questionnaire to answer the question of whether they decided to prescribe migraine prophylaxis and if they had, to give their reasons for doing so. Using logistic regression analysis, we identified the three questions which had the most influence on the decision regarding prophylaxis in the data set. As results, we identified the following three questions: 1. Do you suffer from migraine on more than 3 days/month? 2. Do you have to rest in bed while experiencing a migraine attack? 3. Do you have to take medication against migraine on more than 5 days/month? Validation of this reduced questionnaire is currently ongoing and involves 150 migraine patients of general practitioners.

AB - The aim of the present study was to develop a screening tool to aid non-headache specialists, like general practitioners, in deciding whether migraine prophylaxis in the individual migraine patient is useful or not. The first step was the development of a questionnaire, consisting of 10 items, which was filled in by 132 migraineurs who called on neurologists or headache experts. Independently, the physicians filled in another questionnaire to answer the question of whether they decided to prescribe migraine prophylaxis and if they had, to give their reasons for doing so. Using logistic regression analysis, we identified the three questions which had the most influence on the decision regarding prophylaxis in the data set. As results, we identified the following three questions: 1. Do you suffer from migraine on more than 3 days/month? 2. Do you have to rest in bed while experiencing a migraine attack? 3. Do you have to take medication against migraine on more than 5 days/month? Validation of this reduced questionnaire is currently ongoing and involves 150 migraine patients of general practitioners.

M3 - SCORING: Zeitschriftenaufsatz

VL - 21

SP - 430

EP - 438

JO - SCHMERZ

JF - SCHMERZ

SN - 0932-433X

IS - 5

M1 - 5

ER -